George H. Poste's most recent trade in Caris Life Sciences Inc. - Ordinary Shares - Class A was a trade of 1,600 Common Stock done at an average price of $15.6 . Disclosure was reported to the exchange on May 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caris Life Sciences Inc (Class A) | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 15.62 per share. | 29 May 2026 | 1,600 | 17,729 | - | 15.6 | 24,992 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 8,367 | 127,199 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Sale of securities on an exchange or to another person at price $ 45.71 per share. | 07 May 2026 | 60,000 | 118,832 (0%) | 0% | 45.7 | 2,742,600 | Common Stock |
| Caris Life Sciences Inc (Class A) | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | 11 Aug 2025 | 125,000 | 0 | - | - | Stock Option | ||
| Caris Life Sciences Inc (Class A) | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. | 11 Aug 2025 | 125,000 | 359,754 | - | 2.4 | 305,000 | Common Stock |
| Caris Life Sciences Inc (Class A) | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. | 11 Aug 2025 | 91,495 | 220,237 | - | 29.7 | 2,721,976 | Common Stock |
| Caris Life Sciences Inc (Class A) | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. | 11 Aug 2025 | 48,022 | 311,732 | - | 29.8 | 1,428,655 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 178,832 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Sale of securities on an exchange or to another person at price $ 45.99 per share. | 16 May 2025 | 20,634 | 169,020 (0%) | 0% | 46.0 | 948,958 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | 16 May 2025 | 20,634 | 0 | - | - | Option (right to buy) | ||
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.77 per share. | 16 May 2025 | 20,634 | 189,654 (0%) | 0% | 19.8 | 407,934 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.50 per share. | 14 Feb 2025 | 15,874 | 184,894 (0%) | 0% | 20.5 | 325,417 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Sale of securities on an exchange or to another person at price $ 34.74 per share. | 14 Feb 2025 | 15,874 | 169,020 (0%) | 0% | 34.7 | 551,463 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | 14 Feb 2025 | 15,874 | 0 | - | - | Option (right to buy) | ||
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 01 Nov 2024 | 30,000 | 169,020 (0%) | 0% | 34 | 1,020,000 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Sale of securities on an exchange or to another person at price $ 26.89 per share. | 08 Aug 2024 | 33,725 | 199,020 (0%) | 0% | 26.9 | 906,865 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 18,838 | 232,745 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | 21 May 2024 | 11,686 | 0 | - | - | Option (right to buy) | ||
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Sale of securities on an exchange or to another person at price $ 20.96 per share. | 21 May 2024 | 11,686 | 213,907 (0%) | 0% | 21.0 | 244,939 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.57 per share. | 21 May 2024 | 11,686 | 225,593 (0%) | 0% | 19.6 | 228,695 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 20,718 | 213,907 (0%) | 0% | 0 | - | |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 20,718 | 213,907 (0%) | 0% | 0 | - | |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | 29 Nov 2022 | 40,000 | 0 | - | - | Option (right to buy) | ||
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Sale of securities on an exchange or to another person at price $ 16.68 per share. | 29 Nov 2022 | 40,000 | 193,189 (0%) | 0% | 16.7 | 667,200 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 29 Nov 2022 | 40,000 | 233,189 (0%) | 0% | 6.3 | 252,000 | Common Stock |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 19,575 | 193,189 (0%) | 0% | 0 | - | |
| Exelixis Inc | Dr. George H. Poste, D.V.M.,F.R.S.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 19,575 | 193,189 (0%) | 0% | 0 | - |